Innovation
Search documents
Clorox's Brand Investments Are Up: Will They Translate to Growth?
ZACKS· 2025-12-12 16:30
Core Insights - Clorox Company is increasing brand investments to enhance demand creation strategies, including higher trade spending and advertising, despite ERP-related disruptions [1][4] - The company is focused on innovation across major brands, with new product launches planned for the second half of fiscal 2026 [2] - Clorox's net sales fell 19% year over year to $1.43 billion in Q1 FY26, with organic sales decreasing 17% due to lower shipments related to the ERP transition [3][8] - For fiscal 2026, Clorox projects a net sales decline of 6-10% and organic sales to fall 5-9%, reflecting ongoing short-term pressures [3][8] - The company maintains advertising and promotional spending at approximately 11% of net sales to support long-term brand growth [4][8] Financial Performance - Clorox's shares have decreased by 16.4% over the past six months, compared to an industry decline of 11.9% [5] - The forward price-to-earnings ratio for Clorox is 16.35, which is lower than the industry average of 17.63 [7] - The Zacks Consensus Estimate indicates a 24% year-over-year decline in Clorox's fiscal 2026 earnings, but a projected rise of 15.8% in fiscal 2027 earnings [9]
RH targets 9%–9.2% revenue growth and $250M–$300M free cash flow for fiscal 2025 while innovating amid challenging housing market (NYSE:RH)
Seeking Alpha· 2025-12-12 09:24
Group 1 - The article does not provide any relevant content regarding the company or industry [1]
X @BNB Chain
BNB Chain· 2025-12-12 07:20
RT BNB Chain Developers (@BNBChainDevs)Most people see a hackathon leaderboard but @cz_binance sees something completely different: a starting point.🔸 Resilience Over ResultsShort-term results do not define a builder, what matters is having the resilience to keep going.Every meaningful product in this industry came from years of iteration, pivots, failures and breakthroughs. A weekend doesn't make or break you, the long-term does.🔸 The Market Picks the Real WinnersCZ said during his recent AMA at #BNBHack i ...
深圳上市公司关键数据,重磅发布
Shen Zhen Shang Bao· 2025-12-12 01:24
深圳是创新之城,梦想之城,在前沿创新的赛道上,深圳企业一马当先。2024年,深圳研发经费投入稳居全国大中城市第二位,研发经费投入强度位居全 国首位,为经济高质量发展注入强劲动能。 作为粤港澳大湾区权威、主流财经新媒体,读创客户端上线九周年之际,联合国内头部金融数据服务商同花顺(300033),通过对深圳本地400多家A股 上市公司财报数据的梳理,推出"深圳上市公司创新发展排行榜",从研发人员数量、研发人员/员工比例、研发投入、研发投入/营业收入比例、产品专利 数量等多个维度,描绘深圳上市公司创新发展全景图。从中可以看出,在创新赛道上奋勇争先的深圳企业,无一例外都是"研发健将"。 排行榜显示,比亚迪(002594)目前研发人员数量达12.16万人,2025年上半年研发投入达309亿元,无论是人员数量还是投入金额,都稳居深圳本地上市 公司之首。 以下为"深圳上市公司创新发展排行榜"前30名的具体情况: | | 证券代码 | 证券名称 | 研发人员数量 | | --- | --- | --- | --- | | 4 | 002475.SZ | 立讯精密 | 22,583 | | 5 | 300115.SZ | 长盈 ...
X @Watcher.Guru
Watcher.Guru· 2025-12-11 22:48
Regulatory Landscape - SEC Chair Atkins states US financial markets are moving "on-chain" [1] - SEC is prioritizing innovation and embracing new technologies to enable this on-chain future [1]
Badger Meter Announces Key Executive Leadership Appointments to Further Advance Innovation, Growth, Execution and Customer Experience
Businesswire· 2025-12-11 21:15
MILWAUKEE--(BUSINESS WIRE)--Badger Meter, Inc. (NYSE: BMI), a global leader in smart water management solutions, today announced a series of executive leadership changes effective January 1, 2026. Ken Bockhorst, Chairman, President and Chief Executive Officer, stated: "I am excited to announce key executive leadership changes that align our strategic priorities with a management structure designed to expand our market leadership in cellular Advanced Metering Infrastructure (AMI), while growing. ...
Animal Health Focused Elanco Details Pipeline Momentum, US Investments, Cost-Saving Plans
Benzinga· 2025-12-11 18:25
Core Viewpoint - Elanco Animal Health is entering a new phase focused on sustainable growth, margin expansion, and a stronger balance sheet, as outlined during its first Investor Day in five years [1] Financial Outlook - Elanco projects mid-single-digit organic revenue growth, high-single-digit adjusted EBITDA growth, and low-double-digit adjusted EPS growth starting in 2026 [2] - The company anticipates free cash flow of at least $1 billion from 2026 to 2028, with net leverage expected to fall below 3x in 2027, targeting a long-term range of 2.0x to 2.5x [2] R&D Investments - Elanco plans to expand R&D operations in Indianapolis and increase its U.S.-based manufacturing footprint, including investments in its Kansas monoclonal antibody facility [3] - The company is progressing towards final USDA approval for Befrena, a potential blockbuster dermatitis treatment for dogs, with a launch expected in the first half of 2026 [4] - Elanco forecasts approximately $1.1 billion in revenue from its innovation portfolio in 2026, an increase from prior expectations for 2025 [4] - The company has expanded its focus to eight innovation areas and added two new internal development platforms in monoclonal antibodies and immunotherapy [4] - More than 10 major pipeline programs are expected to carry blockbuster potential, with approvals anticipated for five to six differentiated assets between 2026 and 2031 [5] Cost Initiatives - Elanco detailed its Ascend productivity initiative, expecting $25 million in savings in 2026 and $60 million in 2027, affecting 600 roles through reductions or shifts [6] - A related charge of approximately $175 million is anticipated, with the Ascend program expected to deliver $200 to $250 million in adjusted EBITDA savings by 2030, with about 30% achieved in 2026 [6] - The initiative positions Elanco for durable, profitable growth with continued margin expansion and strong cash generation into the latter half of the decade [7] Analyst Insights - Analysts noted initial details on over 15 projects in key areas, including five to six blockbusters, positioning Elanco for three waves of innovation over the next decade [9] - If Elanco successfully executes its pipeline, it is expected to deliver upside to its long-term financial targets [9] - Elanco shares were trading at 21 times the 2026 EPS estimate, with an Outperform rating maintained by analysts [10]
Learning to Think in a Fast-Changing World | Dr Anil Pinto | TEDxChrist University
TEDx Talks· 2025-12-11 17:12
The year was 2005, the year I joined Christ College, then now Christ University. I had grown up in a rural coastal village, studied in a Canada medium school and I did not share at least I thought I did not share any of the worldview and experiences of the students of Christ University. I was worried whether I will be accepted whether I'll be able to make an impact whether it was a right decision to move from a small town to a big place Bangalore and Christ college then Christ University now so I went fell ...
Cultural Heritage as a Root for Innovation | Dr Rozan Yunos | TEDxUniversiti Brunei Darussalam
TEDx Talks· 2025-12-11 16:54
[applause] If Tam Sultan Amari Saiin could speak, what would it say. If you stand in the middle of the field and close your eyes, you might hear more than just the rustle of the wind. You might hear the call to prayer rising from the nearby mosque of Sultan Omar Ali Seafuin. You might hear the laughter of market traders. You might hear the running footsteps of children.These are not just but they are representatives of the heartbeat of Brunai. Older generations will tell you the field was once called Padang ...
X @Sui
Sui· 2025-12-11 16:04
“Innovation can’t scale without privacy. And privacy can’t scale without new primitives.”@a16zcrypto’s new “17 Things We’re Excited About for Crypto in 2026” features insights from @EmanAbio, cofounder of @Mysten_Labs, the original creators of Sui.👉 https://t.co/ABPScO4swi https://t.co/D9hYMQzCzP ...